BioClinica, Inc. Announces Fourth Quarter and Full Year 2012 Financial Results
BioClinica®, Inc. (NASDAQ: BIOC), a leading global provider of clinical trial management solutions, today announced its financial results for the fourth quarter and full year ended December 31, 2012.